期刊
CELL DEATH AND DIFFERENTIATION
卷 15, 期 5, 页码 820-830出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/cdd.2008.25
关键词
ABT-737; rupture of outer mitochondrial membrane; BCL2; cytochrome c release; CLL
资金
- MRC [MC_U132615750, MC_U132670597] Funding Source: UKRI
- Medical Research Council [MC_U132615750, MC_U132670597] Funding Source: researchfish
- Medical Research Council [MC_U132615750, MC_U132670597] Funding Source: Medline
Primary chronic lymphocytic leukemia (CLL) cells are exquisitely sensitive to ABT-737, a small molecule BCL2-antagonist, which induces many of the classical biochemical and ultrastructural features of apoptosis, including BAX/BAK oligomerization, cytochrome c release, caspase activation and chromatin condensation. Surprisingly, ABT-737 also induces mitochondrial inner membrane permeabilization (MIMP) resulting in mitochondrial matrix swelling and rupture of the outer mitochondrial membrane (OMM), so permitting the rapid efflux of cytochrome c from mitochondrial cristae and facilitating rapid caspase activation and apoptosis. BAX and BAK appear to be involved in the OMM discontinuities as they localize to the OMM break points. Notably, ABT-737 induced mitochondrial matrix swelling and OMM discontinuities in other primary B-cell malignancies, including mantle cell, follicular and marginal zone lymphoma cells but not in several cell lines studied. Thus, we describe a new paradigm of apoptosis in primary B-cell malignancies, whereby targeting of BCL2 results in all the classical features of apoptosis together with OMM rupture independent of caspase activation. This mechanism may be far more prevalent than hitherto recognized due to the failure of most methods, used to measure apoptosis, to recognize such a mechanism.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据